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coating cell culture bottles and modiﬁed CGM is a more superior
method, which lays the foundation for the further experimental
study.
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Effect of Rosiglitazone on Insulin Resistance and ROS/IKK Signaling
Pathway in Vascular Endothelial Cells
Fanghui Chen
The First Afﬁliated Hospital of Gannan Medical University
OBJECTIVES To explore the protective effect of rosiglitazone on in-
sulin resistance (IR) induced by high glucose in vascular endothelial
cells and its possible mechanism.
METHODS Human umbilical vein endothelial cells (HUVECs) was
divided into 3 groups: the normal control group cultivated in DEME
medium with 5.5 mmol/L glucose; the high glucose group (HG)
cultivated in DEME medium with 33 mmol/L glucose for 24 h after the
IR model was set up; the rosiglitazone group cultivated in DEME
medium with 33 mmol/L glucose and 10 mmol/L of rosiglitazone for
24 h after the IR model was set up. The cell viability, nitric oxide(NO),
endothelin-1(ET-1), mitochondrial membrane potential, reactive oxy-
gen species(ROS), p-IKK and IkBa protein levels were detected.
RESULTS Compared with the normal control, the cell viability, the
level of NO and the mitochondrial membrane potential were
decreased, levels of ET-1 and ROS increased, p-IKK expression was
upregulated, and IkBa expression was down-regulated in HG group(all
P<0.01). Rosiglitazone reversed these changes(P<0.05).
CONCLUSIONS Rosiglitazone has the protective effect on insulin
resistance induced by high glucose in vascular endothelial cells via
inhibiting ROS/IKK signaling pathway.GW26-e2914
A study of the mechanism of valsartan pre-protecting adriamycin-induced
cardiotoxicity
Lili Meng, Qin Yu
Afﬁlated Zhongshan Hospital of Dalian University
OBJECTIVES To investigate the effects of valsartan pre-protects
adrimycin-induced cardiotoxicity and the mechanism.
METHODS 61 of 8w SD rats were devided into 4groups as follows:
Control group (n¼9) were feeded normally; adrimycin-induced car-
diotoxicity() group:intraperitoneal ADR,2.5mg/(kg.w), totally 6 weeks,
cumulative dose was 15mg/kg. Group C (n¼17): valsartan (low dose)
intervened (VLD) group, Group D: valsartan(high dose) intervened
group(VHD). In group C and D, valsartan was separately (10mg/(kg.d)
and30mg/(kg.d)) given from the ﬁrst dose of adriamycin, totally 6
weeks. After 6 weeks administration of valsartan and adriamycin,
observed 4 weeks. Use echocardiography to detect LVEF, LVFS,
LVESD, LVEDD. Take the heart out of the chest to do measure hearts’
weight. And then do HE, Sirius red staining. Count out CVF. Use ELISA
kits to detect the content of RAS and ROS in cardiac tissues. Use qRT-
PCR to detect collagen I, collagen III, caspase3 and caspase8’s
expressions.
RESULTS
(1) Compared with blank control group, renin, angiotensin II, aldoste-
rone synthase, ROS in the myocardial tissues of the model group are
evidently overexpressed (P <0.05); In group model, rats’ myocardial
tissue, caspase3, caspase8 mRNA levels increased signiﬁcantly
(P <0.05), the myocardial collagen volume increased signiﬁcantly
(P<0.05).
(2) Valsartan high dose group compared with blank control group, there
was no signiﬁcant statistical differences about indexes above (P
>0.05). compared with model control group, the valsartan high dose
group and the blank control group, there were signiﬁcant differences
about the above indexes (P < 0.05).
(3) There were no signiﬁcant differences in LVEDD among the four
groups (P >0.05); About LVESD, LVEF, LVFS, there were no signiﬁ-
cant difference between the valsatan low dose group and the model
control group. The above index average were less than the model
control group and the valsartan low dose group, The differences
among the three groups were signiﬁcant (P <0.05), Compared with
the high dose group and the blank control group, the above indexes
in model control group were higher. The differences were
signiﬁcant(P <0.05). There were no difference between the valsartan
high dose group and blank control group (P >0.05).CONCLUSIONS
(1) Adriamycin might via activing RAS in rats’ myocardial tissues to
cause angiotensin overexpressed. Angiotensin-stimulatied to
generate more ROS. So the superabundant ROS caused the myocar-
dial apoptosis and ﬁbrosis.
(2) Appling enough dose (load dose) valsartan from the ﬁrst dose of
adriamycin could against AT1 in rats’ myocardial tissues. So it could
down-regulate the expression of NOX1 and NOX4 and the ROS
decreased. In the end, the myocardial apoptosis and ﬁbrosis would
be alleviated. However early application of small dose valsartan had
no protective effect on adriamycin induced cardiotoxicity.
(3) Sufﬁcient and early use of valsartan in adriamycin chemotherapy
rats could prevent rats suffering Cardiotoxicity. The mechanism
might related to NOX1 and NOX4 mediated oxidative stress.GW26-e2924
Endothelial progenitor cells join in HHcy impaired angiogenesis
Xiao Huang, Hong Wang, Xiaoshu Cheng
The second hospital of Nanchang University
OBJECTIVES During the last decade,we and others have demonstrated
that HHcy can inhibit endothelial cell growth and postinjury reendo-
thelialization, accelerate neointimal formation, also can impair endo-
thelial relaxation, stimulate vascular smooth muscle cell proliferation,
and inhibit high-density lipoprotein biosynthesis. However, the
fundamental basis of HHcy-impaired angiogenesis remains unknown,
especially the role of endothelial progenitor cells in angiogenesis.
Role of endothelial progenitor cell in HHcy impaired angiogenesis.
Intravenous transfusions of Sca-1þ cells maybe play a role in HHcy MI
mice angiogenesis.
METHODS
1. Angiogenesis of HHcy mice under myocardial infarction. 1.1 Car-
diac function was measured with echocardiography (VisualSonics
Vevo 770); 1.2 Hearts were moved at 2 weeks/6 weeks after myocardial
infarction and kept at -80C until needed. Frozen heart tissues were
cut into 5mm thick slices. Adjacent sections (taken at the midpoint
between LAD ligation site and apex) were stained with rabbit poly-
clonal antibodies against CD31.
2. Flow cytometry analysis. A volume of 200ml peripheral blood/
bone marrow were incubated for 30 minutes in the dark with mono-
clonal antibodies against mouse vascular endothelial growth factor
receptor 2 (VEGFR2) followed by PE-conjugated secondary antibody.
3. MACS Separation-purify Sca-1þ cells. Purity of Sca-1þ cell is based
on the use of MACS MicroBeads, MACS Columns and MACS Separators.
4. Intravenous transfusions of Sca-1þ cells in HHcy MI mice angio-
genesis. To evaluate the homing to infarcted heart of injected cells,
200ml puriﬁed Sca-1þ cells were labeled with CellVueR NIR (near-
infrared) 780 (Excitation max: 745nm/Emission max: 776nm, Mol.
Targeting Tech. Inc. West Chester, PA) and injected peri-orbitally into
C57/B6 mice, 6 hours before MI procedure.
RESULTS
1. HHcy impairs mouse cardiac function. Ejection fraction (EF) and
fractional shortening (FS) were lower in HHcy mice group than control
group, as well as heart capillary density. HHcy mice hearts have
depressed function and less capillary density after myocardial
infarction stress. Survival rate is also lower in HHcy mice.
2. Peripheral blood derived EPC percentage decreased in HHcy mice
group and bone marrow derived EPC percentage is higher in HHcy
mice group, but cell death rate is also higher in HHcy mice.
3. Intravenous transfusion of Sca-1þ cells treatment induce PB derived
EPC percentage increase in both control mice group and HHcy mice
group. 6 weeks survival rate increased from 12.5% to 27.3% in
hCBSþCbs-/- cell treat group, and also 62.5% to 80% in hCBSþCbsþ/- cell
treat group; The LVEF increased from 19.3% to 38.5% in hCBSþCbs-/- cell
treat group, and also 31.6% to50.9% in hCBSþCbsþ/- cell treat group.
CONCLUSIONS EPC joined angiogenesis after myocardial infarction
which is so important to cardiac function. Cell treatment restores
ischemia-induced angiogenesis in HHcy mice.
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Plaque Thrombosis Are Reduced by Attenuating Plaque Inﬂammation with
Pioglitazone and Are Evaluated by Fluorodeoxyglucose Positron Emission
Tomography
Mingduo Zhang, Shuzheng Lv, Quanming Zhao
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical
University, Beijing Institute of Heart, Lung and Blood Vessel Diseases
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glitazone in reducing clinical events and plaque inﬂammatory burden
remains unknown. This study aims to determine whether pioglitazone
can reduce the number of plaque thrombosis incidences and whether
decreasing plaque inﬂammation is the mechanism by which piogli-
tazone reduces plaque thromboses.
METHODS Atherosclerotic rabbits were divided into two groups: the
atherosclerosis group (n¼13) and pioglitazone group (n ¼ 10). The
rabbits underwent pharmacological triggering to induce thrombosis.
Serum inﬂammatory markers, FDG uptake, macrophage and neovessel
staining detected arterial inﬂammation. PET/CT scans were performed
twice (baseline and post-treatment scans). Plaque area, macrophages,
and neovessels were measured and the histological sections were
matched with the PET/CT scans. Serum MMP-9 and hsCRP were lower
in the pioglitazone group compared to the atherosclerosis group.
RESULTS The SUVmean signiﬁcantly decreased in the pioglitazone
group (0.62  0.21 vs. 0.55  0.19, P ¼ 0.008), but increased in the
atherosclerosis group (0.61  0.15 vs. 0.91  0.20, P < 0.000). The
incidence rate of plaque rupture, plaque area, macrophage density,
and neovessels density was signiﬁcantly lower in rabbits with pio-
glitazone than without (15 % vs. 38 %, P < 0.001; 18.00  2.30 vs. 27.00
 1.60; P < 0.001; 8.80  3.94 vs. 28.26  2.49; P < 0.001; 16.50  3.09
vs. 29.00  2.11; P < 0.001, respectively). Moreover, plaque area and
macrophage density were positively correlated with SUV values.
CONCLUSIONS Our study suggests that pioglitazone can reduce the
number of plaque thrombosis incidences by decreasing plaque
inﬂammation. 18F-FDG-PET/CT can detect plaque inﬂammation and
assess the effects of antiatherosclerotic drugs.
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Effect of Atorvastatin on IKK/NF-lB Pathway of Insulin Resistance in
Vascular Endothelial Cells
Fanghui Chen
The First Afﬁliated Hospital of Gannan Medical University
OBJECTIVES To investigate the inﬂuence of atorvastatin on IKK/NF-
lB Pathway of insulin resistance in vascular endothelial cells.
METHODS Human umbilical vein endothelial cells (HUVECs) were
cultured in vitro with high glucose and insulin to establish a model of
insulin resistance. Then the cells were treated with 10mmol/L of
atorvastatin for 24h. Western blot method were used to assay the
expression of pIKK, IkBa, NF-kB p65 protein. The levels of nitric oxide
(NO), endothelin-1 (ET-1), TNF-a, IL-6, ICAM-1 and VCAM-1 was
measured by enzyme linked immunosorbent assay (ELISA) kits.
RESULTS HUVECs were cultured with high glucose and insulin, the
levels of ET-1, TNF-a, IL-6, ICAM-1 and VCAM-1were increased, level
of NO decreased, p-IKK and NF-kB p65 expression was upregulated,
and IkBa expression was down-regulated (all P<0.05). Atorvastatin
reversed these changes (all P<0.05).
CONCLUSIONS Atorvastatin has the protective effect on insulin
resistance induced by high glucose in vascular endothelial cells. The
underlying mechanism may be connected with inhibition of IKK/NF-
lB Pathway.
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The effect and mechanism of Glucagon-like peptide-1 protects against the
diabetic cardiomyopathy
Qinan Wu, Xiaotian Lei, Xiaguang Gan, Wuquan Deng, Bing Chen,
Ziwen Liang, Ziwen Liang
The ﬁrst afﬁliated Hospital of the Third Military Medical University
OBJECTIVES To investigate the effect and mechanism of Glucagon-
like peptide-1(GLP-1) on diabetic cardiomyopathy.
METHODS All rats were divided into normal group(N), diabetes
group(D, STZ and high fat diet to construct diabetic animal model),
diabetes treat with insulin group (DI) and diabetes treat with Exena-
tide (a glucagon-like peptide-1 receptor agonist) group (DA). After
modeling 12 weeks, we detected cardiac function by multimedia bio-
signal recorder, detected apoptosis rate of cardiomyocyte by TUNEL,
detected blood serum adiponectin by ELISA, detected protein
expression of PPARa, NF-kB by western-blotting.
RESULTS Compare with N group, the cardiac myocyte apoptosis rate of D
group was signiﬁcantly increased, the concentration of adiponectin was
signiﬁcantly decreased(P<0.05), the expression of PPARawas decreased
(P<0.05), the expression of NF-KB were signiﬁcantly increased, LV -dP/dtwas signiﬁcantly decreased, LVEDP was signiﬁcantly increased(P<0.05);
ComparewithDgroup, the apoptosis rate ofDAgroupcardiacmyocytewas
signiﬁcantly decreased(P<0.05), the concentration of adiponectin was
signiﬁcantly increased(P<0.05), the expression of PPARaand LV-dP/dt
were signiﬁcantly increased (P<0.05), LvEDP, the expression of NF-KB
were decreased (P<0.05). Compare with DA group, although the glucose
had no difference (P>0.05), the cardiacmyocyte apoptosis rate and LVEDP
of DI groupwere signiﬁcantly increased(P<0.05), the expression of PPARa
and LV-dP/dt were decreased (P<0.05), the expression of NF-KB was
signiﬁcantly increased, the concentration of adiponectin was signiﬁcantly
decreased(P<0.05).
CONCLUSIONS STZ plus high fat diet can induce diabetes, hypo-adi-
ponectin and lower expression of PPARa, which was contribute to
diabetic cardiomyocyte apoptosis and cardiomyopathy. After treated
with Exinatide, the concentration of plasma adiponectin was signiﬁ-
cantly higher, the expression of PPARa was signiﬁcantly increased,
the expression of NF-kB, and cardiac myocyte apoptosis rate were
decreased, cardiac function of diabetic cardiomyopathy rats was
improved, and this effect was independent with glucose.
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The effects of Local Cardiac Denervation on Cardiac Nerve Sprouting and
Ventricular Electrophysiology after Chronic Myocardial Infarction in Dogs
Rui Jiang, Jugang Chen, Yingying Jin, Jingjie Li
The First Afﬁliated Hospital of Harbin Medical University
OBJECTIVES The aim of this study was to investigate the impact of
the coronary sinus (CS) and great cardiac vein (GCV) peripheral nerves
ablation on cardiac nerve sprouting and ventricular electrophysiology
after chronic MI in dogs.
METHODS Twenty-one anesthetized dogs were randomly divided
into the sham-operation (n ¼ 5), MI (n ¼ 8) and MI- denervation
groups (n ¼ 8), respectively. The dogs were ligated with left anterior
descending branch for MI induction, the CS and GCV peripheral
nerves were ablated by radiofrequency. 4 week after ablation or the
generation of MI, the incidence and duration of ventricular arrhyth-
mias (VA) were monitored for 1h during left stellate ganglion (LSG)
stimulation, and programmed electrical stimulation was performed to
measure the ventricular effective refractory period (ERP) and to
induce ventricular ﬁbrillation threshold (VFT) in all animals. At the
end of experiment, the density of tyrosine hydroxylase (TH) and
growth associated protein 43(GAP43)-positive sympathetic nerve ﬁ-
bers as well as infarct size were also detected. Systemic arterial
pressure and heart rate were monitored during experiment.
RESULTS 4 week after ablation or the generation of MI, two dogs in
only MI group died; the incidence and duration of VA in MI-ablation
group were signiﬁcantly lower than that MI-placebo group during LSG
stimulation (P<0.05), and sustained ventricular tachycardia was
induced in MI group. The infarcted border zone ERP and VFT in MI-
denervation groups were signiﬁcantly improved when compared with
MI group. Furthermore, the TH and GAP43-positive sympathetic
nerve ﬁbers in the cardiac base and infarcted border zone were also
decreased (P<0.05). Systemic arterial pressure and heart rate as well
as infarct size were displayed a marked difference when compared
with MI group (P>0.05).
CONCLUSIONS Using the canine MI model, we showed that local abla-
tion of CS and GCV peripheral nerves improves cardiac nerve sprouting
and ventricular electrophysiology after chronic MI, and reduces the
occurrence of VAwith no obvious effects on heart rate, systemic arterial
pressure and infarct size. Therefore, local cardiac denervation may pro-
tect from ventricular arrhythmias complicating chronic MI.
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Inhibitory Effects of Luofengning-0 Formula on the Growth and
Proliferation of Human Coronary Artery Smooth Muscle Cells and
Endothelial Cells in Vitro: An Exploration of a New Type of Complex
Monomer of Chinese Herbs Eluting Stents
Hongmei Li,1,2 Mengqiong Sun,1,2 Ang Gao,1,2 Zhen Wang,1,2
Xueqing Yang,1,2 Tian Sun,1,2 Changbo Xuan,1,2 Xian Wang1,2
1Institute for Cardiovascular Disease, Beijing University of Chinese
Medicine, Beijing 100700, China; 2Key Laboratory of Chinese Internal
Medicine of Ministry of Education and Beijing, Dongzhimen Hospital
Afﬁliated to Beijing University of Chinese Medic
OBJECTIVES To prove the effectiveness and feasibility of Luofengn-
ing-0 complexes and provide the experimental data for the prevention
of restenosis, we investigated the inhibitory effects of different ratio
